Analysis reveals distinct genomic profiles linked to radiation dose in papillary thyroid carcinoma, suggesting ionizing radiation's role for specific drivers.
Papillary thyroid carcinoma (PTC) incidence increased after childhood exposure to radioactive fallout from the Chornobyl accident. We investigated PTC genomic profiles to distinguish radiation-induced versus sporadic oncogenic drivers by modeling dose and molecular characteristics by driver category: BRAF V600E ( n = 132), RAS mutation ( n = 31), fusions generated from two breakpoints and <20 base pairs (bp) breakpoint gain/loss (Fusion 2B<20bp ; n = 63), or ≥3 breakpoints and ≥1000 bp breakpoint loss ( n = 20). The frequency of Fusion 2B<20bp -PTC increased with increasing thyroid radiation dose, whereas all others declined. Clonal small deletion counts increased with increasing radiation dose for Fusion 2B<20bp -PTC ( P = 5.1 × 10 −4 ) but not other drivers ( P > 0.08). Clonal clock mutational signatures, marking the age of tumor initiation, were associated with age at the accident for Fusion 2B<20bp -PTC ( P = 8.2 × 10 −4 ) but not other drivers ( P > 0.21). Together, these results support a causal role for ionizing radiation in Fusion 2B<20bp -PTC as a group but not other drivers.
No takes yet. Share an insight, caveat, or question.
Karyadi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: